Washington, DC - Since the diagnosis of the first Ebola patient in the United States, we have achieved tremendous progress across all elements of the Administration’s whole-of-government response. In an update provided to President Obama today, White House Ebola Response Coordinator Ron Klain reported that America is far more prepared to cope with Ebola domestically, and much farther along in our efforts to squelch the virus at the source than we were just two months ago, thanks to the work of more than a dozen federal agencies involved in the Ebola response.

Tampa, Florida - CareSync has announced the launch of its Chronic Care Management (CCM) solution today. The radical new communication platform combines the easy-to-use CareSync and CareSync Pro applications with proven concierge services to connect providers with patients, their families & caregivers, and other members of the care team to share valuable health information and facilitate care coordination.

Washington, DC - The U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) is making good on this year’s World AIDS Day theme – Focus, Partner, Achieve: An AIDS-free Generation. PEPFAR is now focusing its resources on areas hardest hit by HIV/AIDS and on evidence-based programs to deliver on the promise of an AIDS-free generation. Its new public-private partnerships allow the program to leverage the U.S. government’s investment and accelerate progress toward epidemiologic control.

Los Angeles, California - UCLA neurophysicists have found that space-mapping neurons in the brain react differently to virtual reality than they do to real-world environments. Their findings could be significant for people who use virtual reality for gaming, military, commercial, scientific or other purposes.

Los Angeles, California - UCLA researchers have pioneered a new methodology to predict why some patients battling advanced melanoma respond well and others do not to the new breakthrough drug pembrolizumab.

Los Angeles, California - Led by Dr. Hanna Mikkola, a member of the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research, UCLA scientists have discovered a protein that is integral to the self-replication of hematopoietic stem cells during human development.